Wooree Bio Co.,Ltd (KOSDAQ: 082850)

Wooree Bio Co.,Ltd Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,263,703	1,263,944	1,355,056	1,543,312	1,623,383	1,672,648
Other Revenue	-0	-0	-	-	0	-0
Revenue	1,263,703	1,263,944	1,355,056	1,543,312	1,623,383	1,672,648
Revenue Growth (YoY)	4.44%	-6.72%	-12.20%	-4.93%	-2.95%	30.71%
Cost of Revenue	1,140,306	1,148,606	1,241,417	1,427,899	1,523,846	1,584,450
Gross Profit	123,397	115,337	113,639	115,412	99,537	88,198
Selling, General & Admin	83,229	74,363	65,396	57,472	47,617	48,471
Research & Development	10,246	8,398	7,019	7,382	6,631	6,566
Other Operating Expenses	1,555	1,350	1,884	1,274	1,376	1,550
Operating Expenses	99,728	89,355	79,398	72,995	62,095	63,873
Operating Income	23,669	25,982	34,241	42,417	37,442	24,325
Interest Expense	-5,457	-6,052	-4,948	-4,438	-6,468	-9,139
Interest & Investment Income	4,229	3,834	1,632	427.15	320.28	397.14
Earnings From Equity Investments	-159.93	-190.83	-123.76	-184.23	13.08	-1,316
Currency Exchange Gain (Loss)	-1,478	-1,908	-116.95	4,510	-2,077	282.09
Other Non Operating Income (Expenses)	-1,480	250.77	1,224	2,566	3,930	-2,666
EBT Excluding Unusual Items	19,323	21,917	31,909	45,298	33,161	11,883
Gain (Loss) on Sale of Investments	6.74	-	-	188.71	-1,865	-169.56
Gain (Loss) on Sale of Assets	8.07	-187.34	117.01	-206.37	-9,019	-41.51
Asset Writedown	-1,811	-	-	-	-52.45	-1,337
Other Unusual Items	-	-	-	-	-	62.76
Pretax Income	17,528	21,729	32,026	45,281	22,224	10,397
Income Tax Expense	5,183	2,783	6,900	1,239	5,241	4,301
Earnings From Continuing Operations	12,345	18,946	25,126	44,041	16,983	6,096
Net Income to Company	12,345	18,946	25,126	44,041	16,983	6,096
Minority Interest in Earnings	-3,680	-3,365	-3,304	-10,886	-141.65	-1,565
Net Income	8,665	15,581	21,822	33,156	16,841	4,532
Net Income to Common	8,665	15,581	21,822	33,156	16,841	4,532
Net Income Growth	-32.83%	-28.60%	-34.18%	96.87%	271.64%	-
Shares Outstanding (Basic)	47	47	46	44	44	42
Shares Outstanding (Diluted)	48	47	46	48	45	45
Shares Change (YoY)	-1.24%	1.95%	-2.87%	5.70%	-	12.46%
EPS (Basic)	183.61	330.98	469.36	750.13	385.66	107.04
EPS (Diluted)	182.64	329.00	469.00	702.06	376.03	106.35
EPS Growth	-30.60%	-29.85%	-33.20%	86.70%	253.57%	-
Free Cash Flow	-27,138	16,018	30,085	38,588	52,167	41,688
Free Cash Flow Per Share	-571.01	337.94	647.10	806.13	1151.92	920.53
Gross Margin	9.76%	9.13%	8.39%	7.48%	6.13%	5.27%
Operating Margin	1.87%	2.06%	2.53%	2.75%	2.31%	1.45%
Profit Margin	0.69%	1.23%	1.61%	2.15%	1.04%	0.27%
Free Cash Flow Margin	-2.15%	1.27%	2.22%	2.50%	3.21%	2.49%
EBITDA	52,204	57,832	70,435	77,974	76,287	64,376
EBITDA Margin	4.13%	4.58%	5.20%	5.05%	4.70%	3.85%
D&A For EBITDA	28,535	31,850	36,194	35,557	38,845	40,051
EBIT	23,669	25,982	34,241	42,417	37,442	24,325
EBIT Margin	1.87%	2.06%	2.53%	2.75%	2.31%	1.45%
Effective Tax Rate	29.57%	12.81%	21.54%	2.74%	23.58%	41.37%
Advertising Expenses	-	9,177	8,633	3,642	246.06	64.8

Source: S&P Capital IQ. Standard template. Financial Sources.